How much funding has Hope Medicine raised?

Hope Medicine has raised $56.0M in total funding, most recently a Venture Round.

Who are Hope Medicine's investors?

Hope Medicine's investors include Sinovation Ventures, TrustBridge Partners, Ennovation Ventures, Qiming VP, Grand Flight Investment, HighLight Capital.

When was Hope Medicine founded?

Hope Medicine was founded in 2019.

Where is Hope Medicine headquartered?

Hope Medicine is headquartered in Shanghai, China.

What industry is Hope Medicine in?

Hope Medicine operates in Biotech, Oncology.

Hope Medicine

Science-driven, patient-centric, clinical-stage biotech company.

Shanghai, China · Founded 2019 · $56.0M raised

Biotech

Oncology

Headquarters: Shanghai
Founded: 2019
Business Model: B2B
Website: hopemedinc.com

Total Funding: $56.0M
Last Round: $56.0M Venture RoundFeb 2024
Rounds: 3

About

Hope Medicine (HopeMed) is a clinical-stage biopharmaceutical company founded on research from Professor Rui-Ping Xiao's lab at Peking University. With R&D bases in Beijing, Shanghai, and Nanjing, the company develops innovative therapies for endocrine, cardiovascular, and metabolic diseases with a focus on women's health. HopeMed's lead asset HMI-115 targets the prolactin receptor under a worldwide exclusive license from Bayer AG.

Summary

Hope Medicine is a Biotech company based in Shanghai, China, founded in 2019. It has raised $56.0M in total across 3 rounds, most recently a $56.0M Venture Round round in Feb 2024. Investors include Sinovation Ventures, TrustBridge Partners and Ennovation Ventures.